Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Vote in favor of your #1 Kind of Cap - 2Why the Houthis waited until now to strike
- 3Experience Is standing by: 10 Pleasant Setting up camp Areas to
- 4Taylor Swift's 'The End of an Era' docuseries: Everything you need to know, plus how to watch for less
- 5Day to day Temporary Positions That Compensate Fairly in the US
- The 2026 'Super Bowl of Astronomy' starts today — here's what's happening
- Famous Network programs in Europe and America
- From Educational Loans to Obligation Free: Independence from the rat race Accomplished
- Live long and loiter: Why NASA's ESCAPADE probes will wait a year in space before heading to Mars
- Astronauts on the ISS watched NASA's historic Artemis 2 launch from space
- Former Peruvian President Pedro Castillo sentenced for conspiracy
- 6 Hints to Upgrade Your Charm, In addition to Your Mentality
- Vacation destinations in America
- Two UN peacekeepers killed in explosion in Lebanon
